452 related articles for article (PubMed ID: 19071180)
1. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
Wittermann C; Petri E; Zent O
Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
[TBL] [Abstract][Full Text] [Related]
4. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
[TBL] [Abstract][Full Text] [Related]
5. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
Beran J; Xie F; Zent O
Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
[TBL] [Abstract][Full Text] [Related]
6. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
[TBL] [Abstract][Full Text] [Related]
8. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
[TBL] [Abstract][Full Text] [Related]
9. Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Laaber B; Wiedermann U; Kollaritsch H
Vaccine; 2009 Nov; 27(50):7027-30. PubMed ID: 19786143
[TBL] [Abstract][Full Text] [Related]
10. Persistence of antibodies after vaccination against tick-borne encephalitis.
Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
[TBL] [Abstract][Full Text] [Related]
11. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
[TBL] [Abstract][Full Text] [Related]
12. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
Vene S; Haglund M; Lundkvist A; Lindquist L; Forsgren M
Vaccine; 2007 Jan; 25(2):366-72. PubMed ID: 16959384
[TBL] [Abstract][Full Text] [Related]
13. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
14. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.
Weinberger B; Keller M; Fischer KH; Stiasny K; Neuner C; Heinz FX; Grubeck-Loebenstein B
Vaccine; 2010 Apr; 28(20):3511-5. PubMed ID: 20332047
[TBL] [Abstract][Full Text] [Related]
15. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
[TBL] [Abstract][Full Text] [Related]
16. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
[TBL] [Abstract][Full Text] [Related]
17. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
18. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
[TBL] [Abstract][Full Text] [Related]
19. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of delayed TBE-vaccine booster.
Askling HH; Vene S; Rombo L; Lindquist L
Vaccine; 2012 Jan; 30(3):499-502. PubMed ID: 22122857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
